Item: Tata India Pharma & Healthcare Fund Direct Growth
Rating: Unrated
Author: Morningstar

Home › Mutual Funds › Tata Mutual Fund › Tata India Pharma & Healthcare Fund Direct Growth

17.815 (2.823%)

NAV on May 20, 2022

Category Equity:
Sector - Healthcare

Investment StyleBox

Large Growth

Total Assets 538 cr

Turnover Ratio

Expense Ratio 1.07%

Exit Load 0.25%if redeemed within
30 Days0.00%if redeemed after 30 Days

Returns

1M: -6.67%
1Y: -0.97%
3M: -2.95%
3Y: 24.48%
6M: -6.89%
5Y: 14.00%

Min Investment 5,000

Buy Now Start SIP

SECTOR WEIGHTINGS (%)

Financial 0.5%

Industrial 0.0%

Technology 0.0%

Basic Materials 0.0%

Consumer Cyclical 0.0%

Utilities Services 0.0%

Healthcare Services 99.50%

Energy Services 0.00%

Communication Services 0.00%

Consumer Defensive 0.00%

Real Estate 0.00%

INVESTMENT OBJECTIVE

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet

Top Rated
Top Performing

-

Best Sector Healthcare Funds

NAME	LATEST NAV	RETURNS 1y	FUND ASSETS	Expense RATIO	RISK
Mirae Asset Healthcare Fund Direct Growth	22.268	0.36%	1,790 cr	0.64%	-
Tata India Pharma & Healthcare Fund Direct Growth	17.815	-0.97%	538 cr	1.07%	-
SBI Healthcare Opportunities Fund Direct Growth	231.291	-5.21%	1,763 cr	1.05%	-